Form 4: MannKind Corp Executive Stuart Tross Reports Acquisition of Restricted Stock Units

Stuart Tross, Chief People & Workplace Officer of MannKind Corp, reports the acquisition of restricted stock units and common stock.

Summary

• On May 15, 2024, Stuart Tross, Chief People & Workplace Officer of MannKind Corp, reported transactions involving MannKind Corp [MNKD] securities.
• Tross acquired 129,000 shares of common stock at $0 and 158,000 performance-based restricted stock units.
• Following these transactions, Tross directly owns 1,145,704 shares of common stock and 158,000 performance restricted stock units.
• The restricted stock units vest in installments starting July 15, 2025, and annually thereafter.
• The performance-based restricted stock units will vest on July 15, 2027, based on MannKind's total shareholder return (TSR) relative to the Russell 3000 Pharmaceutical & Biotechnology Index.

Sentiment

Score: 6

Explanation: The document itself is neutral, simply reporting transactions. The acquisition of shares and restricted stock units by an officer could be interpreted as a mildly positive signal, suggesting confidence in the company's future.

Positives

• The acquisition of restricted stock units and common stock by a company officer can be seen as a positive sign, indicating confidence in the company's future performance.

Future Outlook

The vesting of restricted stock units and performance-based restricted stock units is tied to future dates and performance metrics, indicating a long-term incentive structure for the reporting person.

Industry Context

Stock grants and restricted stock units are common compensation tools in the pharmaceutical and biotechnology industries to align management's interests with those of shareholders and incentivize long-term value creation.

Comparison to Industry Standards

• Equity compensation is a standard practice among publicly traded companies, particularly in the pharmaceutical and biotechnology sectors.
• Companies like Amgen, Gilead Sciences, and Biogen also utilize restricted stock units and performance-based equity awards to incentivize their executives.
• The vesting schedules and performance metrics (such as TSR) are generally aligned with industry best practices to drive long-term shareholder value.

Stakeholder Impact

• The vesting of restricted stock units and performance-based restricted stock units incentivizes the officer to improve company performance, potentially benefiting shareholders.
• The officer's actions are aligned with creating long-term value for the company.

Key Dates